Stomach Cancer Trial, Recruiting NCT04557969 Sponsor: National Cancer Institute (NCI) Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT04557969
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with, or are suspected of having, a type of tumour called a GIST (gastrointestinal stromal tumour), either confirmed by tissue testing or based on clinical findings. If tissue is available from a previous biopsy, that will be reviewed; a new biopsy will not be required if there is not enough tissue to test.
  • People aged 6 years or older.
  • People who are reasonably physically well and able to carry out daily activities, as measured by a standard health scoring scale (confirm with trial site for exact thresholds).
  • People, or their parent or guardian if the person is a child, who are able to understand the trial and are willing to sign a written consent form.

Who may not be able to join:

  • People who have ongoing health conditions that cannot be changed or treated and that would make it unsafe for them to undergo a surgical procedure to remove or reduce the tumour.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Andrew M Blakely, M.D., National Cancer Institute (NCI)

Phone: (240) 858-7573

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
18 December 2020
Est. completion
30 December 2040

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Evaluate and follow patients with GISTs, particularly WT or treatment-refractory non-WT, to support translational research for this rare disease; Assess disease-free intervals (DFIs) between surgical resection of disease for at least 5 years

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov